84
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Inhibitory Effects of the Extracts of Juglans sigillata Green Husks on the Proliferation, Migration and Survival of KYSE150 and EC9706 Human Esophageal Cancer Cell Lines

ORCID Icon, , , , , & show all
Pages 149-158 | Received 20 Dec 2017, Accepted 06 Nov 2018, Published online: 11 Jan 2019
 

Abstract

This study evaluated the antitumor activity of the extracts of green husks of Juglans sigillata Dode on esophageal cancer. KYSE150 EC9706 cells were treated with different concentrations of six components of the extracts of J. sigillata green husks. Cell viability was measured by MTT. Cell migration and cell invasion were measured by wound-healing assays and transwell assays, respectively. Cell apoptosis and cycle were measured by flow cytometry. The expression of cell migration, cell cycle and cell apoptosis regulatory proteins was analyzed by Western blotting. Only the three constituents, including EtOH extractives, EtOAc soluble fraction and gallic acid (GA), exhibited inhibitory effects on the cell viability, migration and invasion by decreasing MMP2 and MMP9 expression (all P < 0.05). Flow cytometry revealed that these three constituents also induced cell apoptosis by increasing Bax and cleaved caspase-3 but decreasing Bcl-2 in KYSE150 and EC9706 cells. Furthermore, these constituents arrested the cell cycle at G0/G1 by downregulating the expression of Cyclin D1 but upregulating p53 and phospho-p53 expression in KYSE150 cells. In conclusion, the green husks of J. sigillata may act as a potential inhibitor on esophageal cancer growth. GA was the major single active constituent of the extracts.

Acknowledgments

The authors thank the technicians of the Department of Tianjin Institute of Acute Abdominal Diseases of Integrated Traditional Chinese and Western Medicine.

Disclosure Statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by and the Foundation from the State Administration of Traditional Chinese Medicine of the People’ Republic of China (No. CC-2; to Xianzhong Wu & Zhigang Li), the National Natural Science Foundation of China (No. 30973383; to Zhigang Li), National and Natural Science Foundation of Tianjin City (No. 13JCZDJC29400; to Chuanling Si) and Technology Foundation of Health and Family Planning Commission of Tianjin (2015KY27; to Caixia Li).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.